Oxytocin - Oxytone Bioscience

Drug Profile

Oxytocin - Oxytone Bioscience

Alternative Names: 14C-labelled oxytocin; Orally disintegrating oxytocin - Oxytone Bioscience

Latest Information Update: 27 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Oxytone Bioscience
  • Class Hormones; Oxytocics
  • Mechanism of Action Oxytocin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Labour disorders

Most Recent Events

  • 12 Apr 2017 Oxytone plans a phase I trial for Labour disorders (In volunteers) (NCT02911480)
  • 27 Sep 2016 Oxytone Bioscience plans a phase I trial for Labour disorders (NCT02908126)
  • 07 Apr 2016 Preclinical trials in Labour disorders in Netherlands (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top